Solu Therapeutics

Solu Therapeutics is a biotech company in Boston, United States, founded in 2023. It has raised $72.0M across 2 rounds, most recently a $41.0M Series A in April 2025.

unlocking Impossible

Employees
1–10
Founded
2023
Business Model
B2B
Total Funding
$72.0M
Last Round
$41.0M Series AApr 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 5 investors for this company. The full record is or through the API.

About

Solu Therapeutics was established in May 2023 following the granting of an exclusive license to the CyTAC platform from GSK. The company is a clinical-stage biotech advancing its lead program through Phase 1 trials in chronic myelomonocytic leukemia, with additional CyTAC and TicTAC programs progressing toward development candidate status. By linking potent and selective small molecules to effector antibodies, Solu's platform targets cell surface proteins that are not addressable using other therapeutic modalities.

Summary

It lists 1–10 employees. It has raised $72.0M in total across 2 rounds, most recently a $41.0M Series A round in Apr 2025. Investors include Hengdian Group Capital, Eli Lilly and DCVC (Data Collab).

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries AApr 2025
$41.0M

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Solu Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/solu-therapeutics"><img src="https://indexed.vc/api/badge/company/solu-therapeutics" alt="Solu Therapeutics on Indexed.vc" width="260" height="76" /></a>